Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor | Patent Number RE046284

US RE046284 E1
Application Number14985148
Publication Number-
Pendency1 year, 26 days
Filled DateDec 30, 2015
Priority DateJan 26, 2005
Publication Date-
Expiration DateJan 25, 2025
Inventor/ApplicantsTomohiro Emura
Akira Mita
ExaminesRAILEY, JOHNNY F
Art Unit3991
Technology Center3900
Assignments
Otsuka Holdings Co. Ltd.
Current
Taiho PharmaceuticalOtsuka Holdings Co. Ltd.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.